EGFR-TKI für fortgeschrittenes NSCLC Marktgröße, Anteilsanalyse bis 2025-2031
EGFR-TKI for Advanced NSCLC Market Report Analysis
EGFR-TKI for Advanced NSCLC Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Beta pharma Ltd
- Actiza pharmaceuticals
- AstraZeneca
- Sun Pharmaceuticals
- Roche
- Teva Pharmaceutical Industries
- Armas Pharmaceuticals, Inc
- Boehringer Ingelheim
- Rewine Pharmaceutical
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Typ
- Gefitinib
- Erlotinib
- Afatinib
- Icotinib
By Therapietyp
- Monotherapie
- Kombinationstherapie
By Endbenutzer
- Krankenhäuser
- Krebszentren
- andere
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For